The global electronic drug delivery systems market size is expected to reach USD 15.4 billion by 2027 registering a CAGR of 8.9%, according to a new report by Grand View Research, Inc. Technological advancements allowing easy self-administration technologies, mainly in infusion pumps and auto injectors that help in large-volume and high-viscosity biologic drugs have created a potential market opportunity for the companies. Approvals of novel drug formulations for use in infusion pumps allow a novel treatment option, thereby advancing diabetes care in adults.
In
October 2019, Novo Nordisk received the U.S. Food and Drug Administration
approval for Fiasp, insulin injection for use in insulin pumps for
patients with type 1 and 2 diabetes. Moreover, the innovative wearable infusion
pumps allow the patients to wirelessly connect to smartphone apps. This enables
healthcare professionals to track patient data and tailor specific therapies as
per individual requirements. The aforementioned factors have augmented the
demand for electronic drug delivery systems globally. However, automated pumps
may have risks of wrong dosage with technical glitches and might lead to
adverse drug reactions. This may hinder the market growth.
Full Research Report On Electronic Drug Delivery Systems Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/electronic-drug-delivery-systems-market
Electronic Drug
Delivery Systems Market Report Highlights
- North America accounted for
the largest share in 2019 owing to high prevalence of chronic diseases,
such as diabetes, heart diseases, asthma, and COPD
- Key companies are adopting
several strategies, such as expansion of production facilities, to cater
to the increasing product demand and thus gain a significant share in the
global market
- By product type, the
wearable infusion pump segment led the market as these pumps provide a
cost-effective alternative with the convenience of a disposable injection
pen and prefilled syringe
- By application, diabetes
segment is expected to register the fastest CAGR due to rising number of
diabetic patients across the globe and frequent drug administration
required to manage the condition
- By distribution channel,
retail pharmacies held the largest market share as they include major
pharmacy chains
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/electronic-drug-delivery-systems-market/request/rs1
Electronic Drug
Delivery Systems Market Segmentation
Grand View Research has segmented
the global electronic drug delivery systems market based on product type,
application, distribution channel, and region:
Electronic Drug
Delivery Systems Product Type Outlook (Revenue, USD Million, 2016 - 2027)
- Wearable Infusion Pumps
- Auto Injectors
- Injection Pens
- Inhalers
Electronic Drug
Delivery Systems Application Outlook (Revenue, USD Million, 2016 - 2027)
- Diabetes
- Cardiovascular Disease
- Respiratory Disorders
- Multiple Sclerosis
- Others
Electronic Drug
Delivery Systems Distribution Channel Outlook (Revenue, USD Million, (2016 -
2027)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Electronic Drug
Delivery Systems Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Thailand
- Malaysia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Qatar
List of Key Players
of Electronic Drug Delivery Systems Market
- Bayer AG
- Gerresheimer AG
- Medtronic PLC
- Elcam Medical Group
- Novo Nordisk
- Insulet Corp.
- Becton, Dickinson and
Company
- Sanofi S.A.
- Unilife Corp.
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment